Gossamer Bio (GOSS) Stock: Buy, Sell, or Hold?
GOSS - Gossamer Bio, Inc. Common Stock
$10.71
-0.22 (-2.01%)
âŧ
5d:
-2.1%
30d:
+6101.51%
90d:
+5395.13%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When GOSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GOSS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GOSS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GOSS is currently trading at $10.71, which is considered slightly high relative to its 30-day fair value range of $1.00 to $11.85.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $10.03, while resistance sits at $12.46.
Market Sentiment: GOSS scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $10.03, while resistance sits at $12.46.
Market Sentiment: GOSS scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.00 -
$11.85
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
35.3%
Protect Your Profits
GOSS is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (11/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.00 -
$11.85
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.03
Resistance Level
$12.46
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.69
Revenue Growth (YoY)
-19.6%
Profit Margin
-235.0%
Share & Embed Analysis
Last updated: October 03, 2026 12:44 AM ET
Data refreshes hourly during market hours. Next update: 1:44 AM
Data refreshes hourly during market hours. Next update: 1:44 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
Advanced GOSS Option Strategies
Professional options setups generated by AI based on today's GOSS price and gamma walls.
